• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Med Surg (Lond) . Pulmonary barotrauma in COVID-19: A systematic review and meta-analysis

tetano

Editor, Senior Moderator
Ann Med Surg (Lond)


. 2022 Jan;73:103221.
doi: 10.1016/j.amsu.2021.103221. Epub 2022 Jan 3.
Pulmonary barotrauma in COVID-19: A systematic review and meta-analysis


Dhan Bahadur Shrestha[SUP] 1 [/SUP], Yub Raj Sedhai[SUP] 2 [/SUP], Pravash Budhathoki[SUP] 3 [/SUP], Ayush Adhikari[SUP] 4 [/SUP], Nisheem Pokharel[SUP] 5 [/SUP], Richa Dhakal[SUP] 6 [/SUP], Satyasuna Kafle[SUP] 7 [/SUP], Wasey Ali Yadullahi Mir[SUP] 1 [/SUP], Roshan Acharya[SUP] 8 [/SUP], Markos G Kashiouris[SUP] 9 [/SUP], Mark S Parker[SUP] 10 [/SUP]



Affiliations

Abstract

Background: An ever-increasing number of studies have reported an increased incidence of spontaneous pulmonary barotrauma such as pneumothorax, pneumomediastinum, and subcutaneous emphysema in patients with COVID-19. We conducted this systematic review and meta-analysis to assess the value and significance of the available data.
Methods: A thorough systematic search was conducted to identify studies of barotrauma in hospitalized patients with COVID-19. Data analysis of case reports was done using a statistical package for the social sciences (SPSS) version 22, and meta-analysis was performed using CMA-3.
Results: We identified a total of 4488 studies after thorough database searching.118 case reports and series, and 15 observational studies were included in the qualitative analysis. Fifteen studies were included in the quantitative analysis. The observational studies reported barotrauma in 4.2% (2.4-7.3%) among hospitalized patients; 15.6% (11-21.8%) among critically ill patients; and 18.4% (13-25.3%) in patients receiving invasive mechanical ventilation, showing a linear relationship of barotrauma with the severity of the disease. In addition, barotrauma was associated with a longer length of hospital stay, more extended ICU stay, and higher in-hospital mortality. Also, a slightly higher odds of barotrauma was seen in COVID-19 ARDS compared with non-COVID-19 ARDS.
Conclusion: COVID-19 pneumonia is associated with a higher incidence of barotrauma. It presents unique challenges for invasive and non-invasive ventilation management. Further studies are required to unravel the underlying pathophysiology and develop safer management strategies.

Keywords: ARDS, Acute Respiratory Distress Syndrome; Barotrauma; COVID-19; COVID-19, Coronavirus Disease 2019; ICU, Intensive Care Unit; IMV, Invasive Mechanical Ventilation; NIPPV, Non-invasive Positive Pressure Ventilation; Pneumomediastinum; Pneumopericardium; Pneumothorax; SARS-Cov-2; Severe acute respiratory syndrome coronavirus-2; Subcutaneous emphysema.
 
Back
Top Bottom